Month: June 2021

Albion Enterprise VCT PLC LEI number: 213800OVSRDHRJBMO720 As required by the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules 4.1 and 6.3, Albion Enterprise VCT PLC today makes public its information relating to the Annual Report and Financial Statements for the year ended 31 March 2021. This announcement was approved for release by the Board of Directors on 28 June 2021. This announcement has not been audited. The Annual Report and Financial Statements for the year ended 31 March 2021 (which have been audited), will shortly be sent to shareholders. Copies of the full Annual Report and Financial Statements will be shown via the Albion Capital Group LLP website by clicking www.albion.capital/funds/AAEV/31Mar2021.pdf.  Investment policy Albion Enterprise VCT PLC (the “Company”) is a Venture Capital Trust and...

A first in Canada, TELUS’ successful Sustainability-Linked Bond offering reinforces its commitment to reducing Scope 1 and 2 greenhouse gas emissions VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) — TELUS announced today it has successfully closed its previously announced offering of $750 million 2.85% senior unsecured Sustainability-Linked Series CAF notes with a long 10-year maturity. The notes were offered through a syndicate of agents led by RBC Capital Markets, as Lead Structuring Agent and Joint Bookrunner, and Scotiabank, as Co-Structuring Agent and Joint Bookrunner, together with BMO Capital Markets, as Joint Bookrunner. “Today, with the successful closing of our inaugural Sustainability-Linked Bond – the first of its kind in Canada – our team is at the forefront of sustainability practices, setting...

Webinar Event to Be Held Tomorrow June 29th at 12pm Eastern / 9am Pacific Time SAN DIEGO, CA, June 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of sepsis and other life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome, announced today that its Chairman and CEO, Jim Joyce will participate in a webinar entitled: “The Evolution of Blood Purification Technologies to Treat Emerging Pandemic Threats, Including COVID-19.”  The event will be held tomorrow at 12pm eastern. Event registration can be accessed through the following link: https://forcewealth.com/portfolio-items/sigyn-06-29/?portfolioCats=28 Prompted by 911 and the October 2001 Anthrax attacks, the industry to support the development of drug and vaccine...

CINCINNATI, June 28, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has re-submitted its application for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) for the company’s SARS-CoV-2 molecular diagnostic test on the Revogene® platform. On February 22, 2021, Meridian voluntarily withdrew its EUA application in order to conduct additional studies based on guidance from the FDA. Meridian completed the additional studies and re-submitted its EUA application on Friday, June 25, 2021. Tony Serafini-Lamanna, Executive Vice President – Diagnostics, said, “We are pleased to have completed these studies and resubmitted our EUA application. We look forward to the FDA’s review of the Revogene...

The conversion price represents a premium to market CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, is pleased to announce that Mr. Greg Siokas, Chief Executive Officer, has reduced the debt of the Company by converting $3.0 million of related party debt personally owed to him in exchange for 500,000 shares of common stock at $6.00 per share on June 25, 2021. The conversion price represents a premium to the previous day’s closing price and is a direct reflection of the commitment of the CEO to the long-term objective of building a diversified pharmaceutical company with an established...

WEST PALM BEACH, Fla., June 28, 2021 (GLOBE NEWSWIRE) — Rennova Health, Inc. (OTC: RNVA), (OTC: RNVAW) (“Rennova” or the “Company”), an owner and operator of rural hospitals in Tennessee, is please to confirm it has closed the agreement with VisualMED Clinical Solutions Corp. (VisualMED) a Nevada based public company, to merge its software and genetic testing interpretation divisions, Health Technology Solutions, Inc. (HTS) and Advanced Molecular Services Group, Inc., (AMSG) and their subsidiaries into VisualMED. These entities will operate as wholly owned subsidiaries of VisualMED which will immediately take the steps required to complete a name and trading symbol change. VisualMED intends to complete the required filings to become compliant with SEC reporting requirements to become a fully reporting company as soon as practical. Rennova...

TORONTO, June 28, 2021 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSXV: DSV; OTCQX: DSVSF) (“Discovery” or “the Company”) is pleased to announce the results of voting at its Annual General Meeting held Friday, June 25, 2021. Shareholders voted in favour of all items put forward by the Board of Directors (“the Board”) and Management. Shareholders voted in favour of the election of all director nominees: Murray John (Chair); Taj Singh; Mark O’Dea; Jeff Parr; Moira Smith; Daniel Vickerman; and Jennifer Wagner. Mr. Vic Chevillon and Mr. Jesus Hernandez-Garza did not stand for re-election for the ensuing year. Taj Singh, President and CEO states: “Discovery would like to thank both Vic and Jesus for their contributions to our success over their tenure and we look forward to working with them as advisors to the Company. On behalf of...